Department of Radiology, The Netherlands Cancer Institute, PO Box 90203, 1006, BE, Amsterdam, The Netherlands.
GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Eur Radiol. 2020 Jun;30(6):3101-3112. doi: 10.1007/s00330-019-06524-x. Epub 2020 Feb 17.
Detection of peritoneal metastases (PM) is key in the staging and management of gastrointestinal and ovarian cancer patients. The purpose of this meta-analysis was to determine the diagnostic performance of CT, PET(CT), and (DW)MRI in detecting PM.
A literature search in Pubmed, Embase (Ovid), and Scopus was performed (January 1997-May 2018) to identify studies reporting on the accuracy of imaging PM in the diagnostic workup of gastrointestinal or ovarian cancers. Inclusion criteria were region-based or patient-based studies comprising > 15 patients, surgery/histology/radiological follow-up as a reference standard, and sufficient data to construct a 2 × 2 contingency table. Two observers performed data extraction. The sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated using a bivariate random-effects model and hierarchical summary operating curves (HSROC) were generated.
Of 3457 citations retrieved, twenty-four articles met all inclusion criteria. Thirty-seven datasets could be extracted for analysis including 20 for CT, 10 for PET(CT), and 7 for (DW)MRI. The pooled sensitivity, specificity, and DOR for the detection of PM for region-based studies for CT were 68% (CI, 46-84%), 88%(CI, 81-93%), and 15.9 (CI, 4.4-58.0) respectively; 80% (CI, 57-92%), 90% (CI, 80-96%), and 36.5 (CI, 6.7-199.5) for PET(CT), respectively; 92% (CI, 84-96%), 85% (CI, 78-91%), 63.3 (CI, 31.5-127.3) for (DW)MRI. In the patient-based group, not enough studies were included to make a pooled analysis for (DW)MRI and PET(CT).
(DW)MRI and PET(CT) showed comparable diagnostic performance for the detection of peritoneal metastases in ovarian and gastrointestinal cancer patients. Since MRI is more widely available than PET(CT) in clinical practice, this potentially is the imaging method of choice in most centers in the future.
• Detection of peritoneal metastases plays an important role in the accurate staging of cancer patients, however, there is no accepted reference standard for the imaging of peritoneal metastases • This meta-analysis shows that (DW)MRI provided the highest sensitivity for the detection of peritoneal metastases in ovarian and gastrointestinal cancer patients • Although (DW)MRI and PET(CT) show a comparable overall diagnostic performance, (DW)MRI seems to be the imaging method of choice since it is more available in daily practice than PET(CT).
检测腹膜转移(PM)是胃肠道和卵巢癌患者分期和治疗的关键。本荟萃分析的目的是确定 CT、PET(CT)和(DW)MRI 在检测 PM 中的诊断性能。
对 Pubmed、Embase(Ovid)和 Scopus 进行文献检索(1997 年 1 月至 2018 年 5 月),以确定报告胃肠道或卵巢癌诊断性检查中 PM 成像准确性的研究。纳入标准为基于区域或基于患者的研究,纳入患者数>15 例,以手术/组织学/影像学随访作为参考标准,并提供足够的数据来构建 2×2 四格表。由两位观察者进行数据提取。使用双变量随机效应模型计算敏感性、特异性和诊断比值比(DOR),并生成分层汇总操作曲线(HSROC)。
在检索到的 3457 篇文献中,有 24 篇符合所有纳入标准。共有 20 项 CT、10 项 PET(CT)和 7 项(DW)MRI 的数据可用于分析。基于区域的 CT 研究中 PM 检测的汇总敏感性、特异性和 DOR 分别为 68%(置信区间,46-84%)、88%(置信区间,81-93%)和 15.9(置信区间,4.4-58.0);80%(置信区间,57-92%)、90%(置信区间,80-96%)和 36.5(置信区间,6.7-199.5)分别为 PET(CT);92%(置信区间,84-96%)、85%(置信区间,78-91%)和 63.3(置信区间,31.5-127.3)为(DW)MRI。在基于患者的组中,由于纳入的研究数量不足,无法对(DW)MRI 和 PET(CT)进行汇总分析。
(DW)MRI 和 PET(CT)在检测卵巢和胃肠道癌患者腹膜转移方面具有相当的诊断性能。由于 MRI 在临床实践中比 PET(CT)更广泛应用,因此在未来大多数中心可能成为首选的影像学方法。
腹膜转移的检测在癌症患者的准确分期中起着重要作用,但目前还没有公认的腹膜转移影像学检测标准。
本荟萃分析表明,(DW)MRI 为卵巢和胃肠道癌患者腹膜转移检测提供了最高的敏感性。
尽管(DW)MRI 和 PET(CT)在整体诊断性能上表现相当,但由于 MRI 在日常实践中比 PET(CT)更普及,因此它似乎是首选的影像学方法。